Pancreatic Islet Function in Nondiabetic and Diabetic BB Rats

A decreased acute insulin response to glucose in islet cell antibody positive humans predicts diabetes. Because the dominant mechanism leading to decreased in vivo acute insulin response to glucose remains unclear, perifused islets were examined before and after diabetes onset in BB rats to assess the role of glucose sensitivity on insulin secretion in individual islets. Islets from normal WF rats, diabetes-prone rats without inflamed islets, diabetes-prone rats with inflamed islets, and diabetic rats were studied at 2.0, 8.3, and 16.7 mM glucose. Immunoreactive insulin from WF islets at 16.7 mM glucose was 0.15 ± 0.02 ng · 0–7 min−1 · islet−1 for the first phase and 1.00 ± 0.05 ng · 7–20 min−1 · islet−1 for the second phase of biphasic secretion, compared with basal secretion of 0.10 ± 0.03 ng · 20 min−1 · islet−1 at 2 mM glucose. Diabetes-prone noninflamed islets showed a 0.20 ± 0.03 ng first-phase secretion, a 1.32 ± 0.13 ng second-phase secretion after 16.7 mM glucose, and 0.093 ± 0.02 ng · 20 min−1 · islet−1 at 2 mM glucose, indicating no intrinsic BB rat strain secretion abnormality. Diabetes-prone inflamed islets had secretions of 0.35 ± 0.02 ng during the first phase (P < 0.05 vs. WF) and 1.78 ± 0.29 ng during the second phase (P < 0.05 vs. WF) after 16.7 mM glucose, with 0.24 ± 0.08 ng · 20 min−1 · islet−1 at 2 mM glucose. Islets derived from diabetic rats had a first-phase secretion of 0.63 ± 0.14 ng (P < 0.05 vs. diabetes-prone noninf lamed and WF) and a second phase of 1.48 ± 0.28 ng (P < 0.05 vs. WF) with 0.30 ng · 20 min−1 · islet−1 at 2 mM glucose. Dose-response studies showed enhanced insulin secretion to each concentration of glucose when compared with controls (WF or diabetes-prone noninf lamed). These data indicate that 1) BB inflamed islets can be isolated for dynamic insulin secretion studies in nondiabetic and diabetic rats; 2) β-cell glucose sensitivity appears enhanced in islets derived from nondiabetic rats with inflamed islets or rats soon after diabetes onset; and 3) the reported impairment of in vivo acute insulin response to glucose in the BB rat model does not result primarily from a decrease in residually functioning β-cell sensitivity to glucose, but rather the data suggest a more important role for decreased residual β-cell mass.

[1]  M. Charles,et al.  Quantitative and functional analyses of spleen and in situ islet immune cells before and after diabetes onset in the NOD mouse. , 1992, Autoimmunity.

[2]  T. Seemayer,et al.  Diabetes prevention in BB rats by inhibition of endogenous insulin secretion. , 1991, Metabolism: clinical and experimental.

[3]  S. Bhathena,et al.  Multiple Alterations in Insulin Responses to Glucose in Islets From 48-h Glucose-Infused Nondiabetic Rats , 1990, Diabetes.

[4]  L. Orci,et al.  Reduced beta-cell glucose transporter in new onset diabetic BB rats. , 1990, The Journal of clinical investigation.

[5]  G. Warnock,et al.  Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer culture. , 1990, The Journal of clinical endocrinology and metabolism.

[6]  J. H. Johnson,et al.  Inhibition of glucose transport into rat islet cells by immunoglobulins from patients with new-onset insulin-dependent diabetes mellitus. , 1990, The New England journal of medicine.

[7]  G. Eisenbarth,et al.  Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. , 1990, Annual review of immunology.

[8]  M. Bihoreau,et al.  In vivo insulin secretion and action in hyperglycemic rat. , 1989, The American journal of physiology.

[9]  R. Thirlby,et al.  Severe Diabetes Induced in Subtotally Depancreatized Dogs by Sustained Hyperglycemia , 1988, Diabetes.

[10]  Å. Lernmark,et al.  Reduced Pancreatic Insulin is Associated with Retarded Growth of the Pancreas in Young Prediabetic BB Rats , 1988, Pancreas.

[11]  R. Alejandro,et al.  A simple method of staining fresh and cultured islets. , 1988, Transplantation.

[12]  Å. Lernmark,et al.  Interleukin-1 potentiates glucose stimulated insulin release in the isolated perfused pancreas. , 1988, Acta endocrinologica.

[13]  J. Nerup,et al.  Islet Cytotoxicity of Interleukin 1: Influence of Culture Conditions and Islet Donor Characteristics , 1987, Diabetes.

[14]  J. H. Johnson,et al.  Loss of insulin response to glucose but not arginine during the development of autoimmune diabetes in BB/W rats: relationships to islet volume and glucose transport rate. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Å. Lernmark,et al.  Insulin release and pancreatic insulin is reduced in young prediabetic BB rats. , 1986, Acta endocrinologica.

[16]  N. Nakamura,et al.  Defect of the First-Phase Insulin Secretion to Glucose Stimulation in the Perfused Pancreas of the Nonobese Diabetic (NOD) Mouse , 1986, Diabetes.

[17]  R. Gleason,et al.  Pre-Type I Diabetes: Linear Loss of Beta Cell Response to Intravenous Glucose , 1984, Diabetes.

[18]  J. Logothetopoulos,et al.  The Onset and Progression of Pancreatic Insulitis in the Overt, Spontaneously Diabetic, Young Adult BB Rat Studied by Pancreatic Biopsy , 1984, Diabetes.

[19]  V. Grill,et al.  Glucose- and arginine-induced insulin and glucagon responses from the isolated perfused pancreas of the BB-Wistar diabetic rat. Evidence for selective impairment of glucose regulation. , 1983, Acta endocrinologica.

[20]  R. Turner,et al.  Islet Changes Induced by Hyperglycemia in Rats: Effect of Insulin or Chlorpropamide Therapy , 1982, Diabetes.

[21]  T. Seemayer,et al.  Dynamic time course studies of the spontaneously diabetic BB Wistar rat. III. Light-microscopic and ultrastructural observations of pancreatic islets of Langerhans. , 1982, The American journal of pathology.

[22]  E. Marliss,et al.  The spontaneously diabetic Wistar rat (the "BB" rat). Studies prior to and during development of the overt syndrome. , 1978, Diabetologia.

[23]  R. Pictet,et al.  Insulin secretion. Interrelationships of glucose, cyclic adenosine 3:5-monophosphate, and calcium. , 1975, The Journal of biological chemistry.